ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,723.55
0.36%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Incannex Healthcare Ltd (IXHL) Share Price

IXHL Incannex Healthcare Ltd

2.83
-0.16 (-5.35%)
01 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Incannex Healthcare Ltd NASDAQ:IXHL NASDAQ Common Stock  Common Stock Par Value 0.0001
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.16 -5.35 2.83 2.31 3.98 3.13 2.78 2.99 32,394 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Med, Dental, Hosp Eq-whsl 1.01M -19.98M -1.2587 -0.04 793.66k
 Type  Size  Price  Time  Units 
 9 1 3.03 22:43:59 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore IXHL News
30/05/202413:30EDGAR2Form 8-K - Current report
30/05/202412:30GLOBEPatient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
07/05/202412:30GLOBEIncannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder
16/04/202413:00GLOBEIncannex Healthcare Inc. Quarterly Update, Q1 2024
28/02/202412:30GLOBEIncannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
16/02/202413:00EDGAR2Form 8-K - Current report
16/02/202412:30GLOBEIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
Period
Draw mode
Data Downloads for IXHL

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Incannex Healthcare Ltd Articles